Biotech Values

[urche]

Re: Call me crazy…

Some might call me lucky.

Here's a trading anecdote. I placed several GTCB sell orders last night at prices from 1.62 to 1.79. By luck, Vanguard sold a chunk for me at 1.63, the high for the day. I then repurchased the same shares at 1.25 a few minutes later, a few pennies above the low for the day. I am not a day trader, but that was pretty darn fun....until I realized how many thousands of dollars I lost today overall.

DEW, FWIW, I think the chances of EMEA requesting a new study are <25%. But, I think there is higher chance that some EMEA commisioners want to know how soon the US ATryn could be completed and are going to ask for feasibility or outright demand that approval be deferred until after that study.

So, I fear GTCB is dead money for a number of months.

Urche